Camille Guérin

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

WikiDoc Resources for

Camille Guérin

Articles

Most recent articles on Camille Guérin

Most cited articles on Camille Guérin

Review articles on Camille Guérin

Articles on Camille Guérin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Camille Guérin

Images of Camille Guérin

Photos of Camille Guérin

Podcasts & MP3s on Camille Guérin

Videos on Camille Guérin

Evidence Based Medicine

Cochrane Collaboration on Camille Guérin

Bandolier on Camille Guérin

TRIP on Camille Guérin

Clinical Trials

Ongoing Trials on Camille Guérin at Clinical Trials.gov

Trial results on Camille Guérin

Clinical Trials on Camille Guérin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Camille Guérin

NICE Guidance on Camille Guérin

NHS PRODIGY Guidance

FDA on Camille Guérin

CDC on Camille Guérin

Books

Books on Camille Guérin

News

Camille Guérin in the news

Be alerted to news on Camille Guérin

News trends on Camille Guérin

Commentary

Blogs on Camille Guérin

Definitions

Definitions of Camille Guérin

Patient Resources / Community

Patient resources on Camille Guérin

Discussion groups on Camille Guérin

Patient Handouts on Camille Guérin

Directions to Hospitals Treating Camille Guérin

Risk calculators and risk factors for Camille Guérin

Healthcare Provider Resources

Symptoms of Camille Guérin

Causes & Risk Factors for Camille Guérin

Diagnostic studies for Camille Guérin

Treatment of Camille Guérin

Continuing Medical Education (CME)

CME Programs on Camille Guérin

International

Camille Guérin en Espanol

Camille Guérin en Francais

Businness

Camille Guérin in the Marketplace

Patents on Camille Guérin

Experimental / Informatics

List of terms related to Camille Guérin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Jean-Marie Camille Guérin (b. December 22, 1872, Poitiers, France; d. June 9, 1961, Paris. French veterinarian, bacteriologist and immunologist who, together with Albert Calmette developed the Bacillus Calmette-Guérin (BCG), a vaccine for immunization against tuberculosis.

Camille Guérin was born in Poitiers to a family of modest means. His father died of tuberculosis in 1882 (as well as his wife, in 1918). He studied veterinary medicine at the Ecole Nationale Vétérinaire d'Alfort from 1892 to 1896, working, while a student, as an assistant to pathologist Edmond Nocard (1850-1903).

In 1897, he joined the Pasteur Institute in Lille and started to work with its director, French physician, bacteriologist and immunologist Albert Calmette (1863-1933). He started as a technician in charge of preparing Calmette's serum (antivenom against snake bites) and the vaccine against smallpox. He improved considerably the production techniques of the later, by using rabbits as intermediate hosts, and developed also a method to quantify the remaining virulence of these vaccines.

At Lille, he was promoted to Head of Laboratory in 1900. Thereafter, from 1905 to 1915, and from 1918 to 1928 he devoted himself to the research on a vaccine against tuberculosis, in close association with Calmette, until his death in 1933. He discovered in 1905 that the bovine tuberculosis bacillum, the Mycobacterium bovis, could immunize the animals without causing the disease. Henceforth, he and Calmette developed ways of attenuate the pathogenic activity of Mycobacterium, using successive transferrals of culture. In 1908, after successfully obtaining an immunologically active preparation that could be use to produced a vaccine, he published with Calmette the results of what was named the BCG.

In 1919 he was promoted again, this time to Head of Services. Finally, in 1921, after 230 passages of the BCG culture, they obtained an effective vaccine that could be used in humans. In 1928 he moved to Paris to became the director of the Tuberculosis Service at the Pasteur Institute.

In 1939 he became vice-president of the "Comité National de Défense contre la Tuberculose" (National Defense Committee against Tuberculosis). In 1948 Guérin was chairman of the First International Congress on BCG. He was also President of the Veterinary Academy of France (1949), and President of the Academy of Medicine (1951). In 1955, the French Academy of Sciences awarded him the Scientific Grand Prix.

He died aged 89, in the Hôpital Pasteur in Paris.

External links


de:Jean-Marie Camille Guérin

fr:Camille Guérin

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools